Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis

被引：0
|
作者：
Robyn Bruen
Sean Curley
Sarina Kajani
Daniel Crean
Marcella E. O’Reilly
Margaret B. Lucitt
Catherine G. Godson
Fiona C. McGillicuddy
Orina Belton
机构：
[1] UCD Conway Institute,Diabetes Complications Research Centre, School of Biomolecular and Biomedical Science
[2] University College Dublin,Diabetes Complications Research Centre, School of Medicine
[3] UCD Conway Institute,Diabetes Complications Research Centre, School of Veterinary Medicine
[4] University College Dublin,School of Medicine, Department of Pharmacology and Therapeutics
[5] UCD Conway Institute,undefined
[6] University College Dublin,undefined
[7] Trinity College Dublin,undefined
[8] The University of Dublin,undefined
来源：
Cardiovascular Diabetology | / 16卷
关键词：
MΦ2 macrophages; Monocytes; Anti-inflammatory; Plaque microenvironment; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Macrophage-derived apolipoprotein E increases atherosclerosis in LDL receptor-deficient mice
    Shi, WB
    Lusis, AJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A54 - A54
  • [42] Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice
    Smith, Donald D.
    Tan, Xiaoyu
    Raveendran, Vineesh V.
    Tawfik, Ossama
    Stechschulte, Daniel J.
    Dileepan, Kottarappat N.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (12): : H2612 - H2621
  • [43] Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice
    Poch, Enric
    Carbonell, Paz
    Franco, Sonia
    Diez-Juan, Antonio
    Blasco, Maria A.
    Andres, Vicente
    FASEB JOURNAL, 2004, 18 (02): : 418 - 420
  • [44] Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice
    Iwai, M
    Chen, R
    Li, Z
    Shiuchi, T
    Suzuki, J
    Ide, A
    Tsuda, M
    Okumura, M
    Min, LJ
    Mogi, M
    Horiuchi, M
    CIRCULATION, 2005, 112 (11) : 1636 - 1643
  • [45] Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice
    Lu, Junyan
    Xiang, Guangda
    Liu, Min
    Mei, Wen
    Xiang, Lin
    Dong, Jing
    ATHEROSCLEROSIS, 2015, 243 (02) : 438 - 448
  • [46] Effect of Pioglitazone on the Development of Atherosclerosis and its Underlying Mechanisms in Diabetic Apolipoprotein E-Null Mice
    Gao, Hongli
    Li, Weiping
    Shen, Xuhua
    Di, Beibing
    Li, Hongwei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C6 - C6
  • [47] Proteomic profiling in apolipoprotein E-deficient mice during atherosclerosis progression
    Dursun, Evrim
    Ozben, Beste
    Monari, Emanuela
    Cuoghi, Aurora
    Tomasi, Aldo
    Ozben, Tomris
    ACTA HISTOCHEMICA, 2010, 112 (02) : 178 - 188
  • [48] Decorin overexpression reduces the development of early atherosclerosis in Apolipoprotein E-deficient Mice
    Zen, AA
    Caligiuri, G
    Sainz, J
    Lemitre, M
    Lafont, A
    EUROPEAN HEART JOURNAL, 2004, 25 : 145 - 145
  • [49] An oral ApoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Van Lenten, BJ
    Wagner, AC
    Hama, S
    Hough, G
    Bachini, E
    Garber, DW
    Mishra, VK
    Palgunachari, MN
    Fogelman, AM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) : 1932 - 1937
  • [50] Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient mice
    Hayek, T
    Hamoud, S
    Keidar, S
    Pavlotzky, E
    Coleman, R
    Aviram, M
    Kaplan, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (01) : 140 - 147
12345